help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orfao, A.
Right arrow Articles by San Miguel, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orfao, A.
Right arrow Articles by San Miguel, J. F.

American Journal of Pathology, Vol 149, 1493-1499, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration

A Orfao, L Escribano, J Villarrubia, JL Velasco, C Cervero, J Ciudad, JL Navarro and JF San Miguel
Servicio Central de Citometria, Hospital Clinico Universitario, Salamanca, Spain.

In the present paper we have used a three-color immunofluorescence procedure combined with flow cytometry cell analysis and sorting for the identification and enumeration of human mast cells in both normal and pathological bone marrow samples. Our results show that bone marrow mast cells are clearly identifiable on the basis of their light-scatter properties and strong CD117 expression. These cells were negative for the CD34, CD38, and BB4 antigens. In addition, they were CD33+ and displayed a high reactivity for the anti-IgE monoclonal antibody. The identity of the CD117-strong+ cells (mast cells) was confirmed by both microscopic examination and flow cytometry analysis. The overall frequency of mast cells in the bone marrow samples analyzed in the present study was constantly lower than 1%. The lowest frequencies corresponded to normal human bone marrow samples (0.0080 +/- 0.0082%) and the highest to those patients suffering from indolent systemic mast cell disease (0.40 +/- 0.13%). In summary, our results show that the identification and enumeration of bone marrow mast cells can be achieved using multiparametric flow cytometry. Moreover, once identified, mast cells are suitable for being characterized from the phenotypic and the functional point of view, facilitating the comparison between normal and abnormal mast cells.


This article has been cited by other articles:


Home page
BloodHome page
G.-H. Schernthaner, J.-H. Jordan, M. Ghannadan, H. Agis, D. Bevec, R. Nunez, L. Escribano, O. Majdic, M. Willheim, C. Worda, et al.
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells
Blood, December 15, 2001; 98(13): 3784 - 3792.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Escribano, A. Orfao, B. Diaz-Agustin, J. Villarrubia, C. Cervero, A. Lopez, M. A. G. Marcos, C. Bellas, S. Fernandez-Canadas, M. Cuevas, et al.
Indolent Systemic Mast Cell Disease in Adults: Immunophenotypic Characterization of Bone Marrow Mast Cells and Its Diagnostic Implications
Blood, April 15, 1998; 91(8): 2731 - 2736.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. B. White, J. A. Eisen, T. L. Kasten, and R. D. Fernald
Second gene for gonadotropin-releasing hormone in humans
PNAS, January 6, 1998; 95(1): 305 - 309.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.